Improvements in Patient-Reported outcomes Following 52 Weeks of Treatment with Certolizumab Pegol in Combination with Methotrexate in Dmard-Naive Patients with Severe, Active and Progressive Rheumatoid Arthritis- Results from the C-Early Ra ...

Full Text

PRS37 RACIAL DISPARITIES IN UTILIZATION OF ASTHMA CONTROLLER DRUGTHERAPY

V Vaidya MA Hufstader

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now